secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aditxt, Inc. (ADTX)
CIK:        0001726711
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001213900-24-039238
Event type: m_and_a
Sentiment:  negative
Materiality: 0.75
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Evofem terminates merger with Aditxt due to Aditxt's failure to make Initial Parent Equity Investment
--------------------------------------------------------------------------------

- Evofem Biosciences terminated Merger Agreement effective April 26, 2024.
- Termination due to Aditxt's failure to provide the Initial Parent Equity Investment as defined in the agreement.
- The Merger would have resulted in Evofem becoming a wholly owned subsidiary of Aditxt.
- Aditxt had previously disclosed the Merger Agreement in December 2023.
- The termination is immediate per Evofem's notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726711/000121390024039238/0001213900-24-039238-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726711/000121390024039238/ea020519701-8k_aditxt.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-039238

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer